These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22527222)

  • 1. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
    Ringelstein M; Jung A; Berger K; Stoll M; Madlener K; Klötzsch C; Schlachetzki F; Stolz E
    J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
    Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
    Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 gene and extension of postsurgical calf vein thrombosis.
    Ferrara F; Meli F; Raimondi F; Montalto S; Cospite V; Novo G; Novo S
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):237-42. PubMed ID: 23222167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between PAI-1 4G/5G genotype and residual thrombus in acute mesenteric venous thrombosis.
    Liu B; Feng H; Li W
    Mol Biol Rep; 2024 Sep; 51(1):1001. PubMed ID: 39302481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.
    Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Miletich JP
    Circulation; 1997 Jan; 95(1):59-62. PubMed ID: 8994417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
    Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4G/5G polymorphism modulates PAI-1 circulating levels in obese women.
    Fernandes KS; Sandrim VC
    Mol Cell Biochem; 2012 May; 364(1-2):299-301. PubMed ID: 22258825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.
    Vuckovic BA; Djeric MJ; Tomic BV; Djordjevic VJ; Bajkin BV; Mitic GP
    Blood Coagul Fibrinolysis; 2018 Jan; 29(1):19-24. PubMed ID: 28777103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study.
    Giurgea GA; Brunner-Ziegler S; Jilma B; Sunder-Plassmann R; Koppensteiner R; Gremmel T
    Thromb Res; 2017 May; 153():71-75. PubMed ID: 28347810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to lyse venous thrombi because of elevated plasminogen activator Inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1/4G Syndrome).
    Bern MM; McCarthy N
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):574-8. PubMed ID: 20724304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis.
    Grubic N; Stegnar M; Peternel P; Kaider A; Binder BR
    Thromb Res; 1996 Dec; 84(6):431-43. PubMed ID: 8987164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.
    Barcellona D; Fenu L; Cauli C; Pisu G; Marongiu F
    Thromb Haemost; 2003 Dec; 90(6):1061-4. PubMed ID: 14652637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.